Kroger Specialty Pharmacy Recalls Otezla 30 mg Tablets for Processing Control Issues
Kroger Specialty Pharmacy is recalling Otezla 30 mg tablets due to a lack of processing controls. The affected lots were dispensed in five states between December 2017 and February 2018.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or deaths. The hazard is a manufacturing process issue ('Lack of Processing Controls') without specific reported harm, fitting the criteria for a moderate severity score.
Plain-English summary
Kroger Specialty Pharmacy, Inc. is recalling Otezla 30 mg tablets (NDC 59572-0631-06, 30-day supply) due to a lack of processing controls. The recall covers all lots remaining within their expiration date that were dispensed between December 1, 2017, and February 12, 2018.
The affected products were distributed in Mississippi, Louisiana, Arkansas, Illinois, and Florida. The specific quantity of units recalled is not stated in the source text.
Consumers who have this medication should contact their healthcare provider or pharmacist for guidance on what to do with the recalled product.
The recalled product
- Product
- Otezla 30 mg tablet NDC 59572-0631-06 30 days supply;
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Distribution
Part of a larger recall action
This product is one of 67 recalled by Kroger Specialty Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same manufacturer · Kroger Specialty Pharmacy, Inc.
See all →- HighKroger Recalls Botox Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Capecitabine Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cimzia 200 mg/mL PFS Kits
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Lupron Depot Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cyclophosphamide Capsules Due to Processing Controls
FDA (Drugs) · 2018-05-16
Same hazard · processing control deficiency
See all →- ModerateDoxycycline oral suspension recalled for insanitary manufacturing conditions
FDA (Drugs) · 2022-07-13
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
Similar recalls
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- SevereDr. Reddy's Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-11-13
- SevereLegacy Pharmaceutical Recalls Atenolol Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2017-03-29
- SevereEagle Pharma Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- ModerateMasterPharm Recalls Sildenafil Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05